Evidence map›Paper›PMID 30353220›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2019

Activation of the sweet taste receptor T1R3 by sucralose attenuates VEGF-induced vasculogenesis in a cell model of the retinal microvascular endothelium.

Polina Lizunkova, Emmanuella Enuwosa, Havovi Chichger

Open access · hybridAbstract read
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. AI-driven discovery of blood xenobiotic biomarkers in neovascular age-related macular degeneration using iterative random forests.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Polina LizunkovaBiomedical Research Group, Department of Biomedical and Forensic Sciences, Anglia Ruskin University, East Road, Cambridge, CB1 1PT, UK.
Emmanuella EnuwosaBiomedical Research Group, Department of Biomedical and Forensic Sciences, Anglia Ruskin University, East Road, Cambridge, CB1 1PT, UK.
Havovi ChichgerBiomedical Research Group, Department of Biomedical and Forensic Sciences, Anglia Ruskin University, East Road, Cambridge, CB1 1PT, UK. Havovi.Chichger@anglia.ac.uk.ORCID http://orcid.org/0000-0002-8549-7583
Anglia Ruskin University · GB

Funding

American Heart Association 13POST16860031Diabetes UK 15/0005284Wellcome TrustWellcome Trust 202624/Z/16/Z
6 · The paper itself

Abstract

backgroundOne of the most prevalent microvascular complications for patients with diabetes is diabetic retinopathy (DR) associated with increased retinal endothelial blood vessel formation. Treatments to reduce vascularisation in the retinal endothelium are linked to improved sight in patients with DR. Recently, we have demonstrated the novel protective role of the artificial sweetener, sucralose, and the sweet taste receptor, T1R3, in the pulmonary endothelium to reduce vascular leak. In the present study, we examined the role of sucralose and sweet taste receptors on vasculogenic processes (proliferation, migration, adhesion and tube formation) in a cell model of the retinal endothelium.

methodsWe exposed human retinal microvascular endothelial cells (RMVEC) to VEGF as an in vitro model of DR in the presence and absence of T1R3 agonist sucralose.

resultsIn RMVEC, we observed increased VEGF-induced cell proliferation, migration, adhesion and tube formation, which was significantly attenuated by exposure to the artificial sweetener sucralose. Following siRNA knockdown of the sweet taste receptor, T1R3, but not T1R2, the protective effect of sucralose on VEGF-induced RMVEC vasculogenic processes was blocked. We further demonstrate that sucralose attenuates VEGF-induced Akt phosphorylation to protect the retinal microvasculature.

conclusionThese studies are the first to demonstrate a protective effect of an artificial sweetener, through the sweet taste receptor T1R3, on VEGF-induced vasculogenesis in a retinal microvascular endothelial cell line.

Indexed as

Gene Expression RegulationBlotting, WesternCell LineCell MovementCell ProliferationDiabetic RetinopathyEndothelium, VascularEnzyme-Linked Immunosorbent AssayHumansMicrovesselsReal-Time Polymerase Chain ReactionReceptors, G-Protein-CoupledRetinal NeovascularizationRetinal VesselsRNASucroseReceptors, G-Protein-CoupledRNASucrosetaste receptors, type 1trichlorosucroseArtificial sweetenersDiabetic retinopathyEndotheliumSweet taste receptorsVasculogenesis

Identifiers

PMID30353220
PMCPMC6323138
OpenAlexW2897682381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.